Compsrison of two medicines dexmedetomidine and midazolam given through nasal route in children undergoing heart related procedures, for sedation and easy separation from their parents.
Phase 4
- Conditions
- Health Condition 1: F419- Anxiety disorder, unspecified
- Registration Number
- CTRI/2021/08/035746
- Lead Sponsor
- Vardhman Mahavir Medical College and Safdarjung Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children aged 1 to 10 years, American Society of Anaesthesiologists (ASA) physical status II to III, of either sex.
Exclusion Criteria
1.Those with known allergy to
dexmedetomidine and midazolam.
2.Difficult airway.
3.Haemodynamically unstable children
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Child Parent Separation Score of 1Timepoint: Child Parent Separation Score Assessment at 10 min
- Secondary Outcome Measures
Name Time Method Ramsay Sedation Score of 2Timepoint: Assessment at 10 min